According to a recent market study published by Growth Market Reports, titled, "Global Contrast Media Injectors Market by products, by injector types, by applications, by end-users, and by regions: Size, Share, Trends and Opportunity Analysis, 2017-2027", the market was valued at USD 1,027.9 Million in 2019 and is expected to grow at a rate of 6.8% by 2027. The contrast media injectors market is anticipated to grow significantly during the forecast period. Increasing demand for non-invasive and minimally invasive surgeries, increasing occurrence of several chronic diseases, rising research and development activities in the healthcare sector, and rising approvals for contrast agents are some of the factors contributing to the market growth.

Request a free sample copy @ https://growthmarketreports.com/request-sample/2598

The global contrast media injectors market has been segmented into products, injector types, applications, end-users and regions. In terms of products, the contrast media injectors market is divided into injector systems, consumables, and accessories. The injector system is further divided into CT injectors, MRI injectors, and DSA injectors. The consumables segment is further segmented into syringes, tubes, and others.

Based on injector types, the contrast media injectors market is categorized as dual-head injectors, single-head injectors, and syringe less injectors. In terms of applications, the contrast media injectors market is segmented into interventional radiology, radiology, and interventional cardiology. In terms of end-users, the contrast media injectors market is categorized as hospitals, diagnostic centers, and Ambulatory Surgery Centers (ASCs). On the basis of regions, the job description management software market is segmented as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

Growing prevalence of several chronic diseases, such as cancer, cardiovascular diseases, neurological, and orthopedic diseases, is anticipated to boost the market. Cases of chronic diseases requiring accurate diagnosis through different imaging systems such as computed tomography (CT) scanners and magnetic resonance imaging (MRI) equipment that requires contrast media injectors. Growing adoption of poor lifestyle is increasing incidences of chronic diseases, which is projected to drive the contrast media injectors market during the forecast period.

COVID-19 has hampered the R&D of contrast media injectors, as a majority of research activities were halted due to guidelines of social distancing. Government approvals for contrast media injectors are temporarily on hold, as the market is currently focused on clinical trials of COVID-19 vaccines. Approvals for non-essential goods are kept on hold or delayed due to the pandemic. The demand for contrast media injectors decreased during the pandemic due to trade and supply chain issues; however, the demand was not affected on a huge extent, as these products are pertained to health.

Key Takeaways from the Study

  • North America is expected to dominate the market during the forecast period, due to factors such as growing incidence of minimally invasive procedures and rising prevalence of chronic diseases owing to changing lifestyles.
  • Europe region hold substantial share in the market during the forecast period, due to the local presence of various leading companies, such as Bracco Group, and others.
  • The market in Asia Pacific is expected to expand at a considerable CAGR during the forecast period, due to rising favorable demographic situations in China.
  • The consumables segment is expected to hold a significant share of the market and is projected to expand at a substantial CAGR during the forecast period, owing to rising requirement of consumables in order to maintain hygienic and safety conditions during diagnostic procedures.
  • The radiology segment is expected to expand at a significant pace during the forecast period, due to increasing number of radiology techniques using contrast media injectors.
  • The market in Asia Pacific is expected to gain 167.3 BPS during forecast period 2020-2027. The North America, Europe, Latin America and Middle East & Africa are expected to lose 80.0, 14.5, 36.4, and 36.4 BPS respectively, during the forecast period.
  • The market in Asia Pacific is anticipated to expand at a significant CAGR during the forecast period, owing to factors such as growing R&D investments and favorable demographic scenario in countries such as China.
  • The largest bubble, i.e., North America is expected to hold significant market share position during forecast period.

Report Scope

Report Metric

Details

Market Value in 2019

USD 1,027.9 Million

Market Growth Rate (from 2020 to 2027)

6.8%

Historical Data

2017 & 2018

Base Year

2019

Forecast Period

2020 – 2027

Market Segments

Products, Injector Types, Applications, End-Users, and Regions.

Region Scope

North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Key Companies Profiled

ulrich GmbH & Co. KG, GENERAL ELECTRIC COMPANY, Bayer HealthCare LLC, Bracco Imaging S.p.A., Guerbet, SINO MDT, APOLLO RT Co. Ltd.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail tailor-made purchase options to meet your research requirements.

Target Audience

  • Demand Side: Healthcare Industry, Pharmaceutical Company, Imaging Procedures, and others.
  • Regulatory Side: Concerned government authorities, commercial research & development (R&D) institutions, and other regulatory bodies.
  • Associations and Industry Bodies: The Occupational Safety and Health Administration (OSHA), the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), and others.